Divi’s Laboratories reported a significant rise in profit and EBITDA for Q2 FY2024. Profit for the July-September 2024 quarter stood at ₹510 crore, a 46.5% increase from ₹348 crore in the same period last year. Revenue for Q2 was ₹2,338 crore, up by 22.5% year-on-year from ₹1,909 crore.
EBITDA reached ₹716 crore for the quarter, marking a 49.5% rise compared to ₹479 crore in Q2 2023. The EBITDA margin for Q2 expanded by 500 basis points to 30.6%, compared to 25% in the prior year. For H1 FY2024, Divi’s recorded a total income of ₹4,640 crore, reflecting growth from ₹3,854 crore in the same half of the previous fiscal year.
Profit before tax for H1 FY2024 came in at ₹326 crore, as opposed to ₹961 crore in the year-ago period. Half-year PAT reached ₹940 crore, up from ₹704 crore in H1 FY2023. The company also saw a forex gain of ₹28 crore in the current half-year, doubling from ₹14 crore in the previous year’s comparable period.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice